Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Poll Archives

An RA patient complains of ongoing joint pain and tenderness without swelling in multiple joints despite treatment with MTX and a biologic. CRP, ESR are normal. What would you do?

  • D. Treat the pain (61%)
  • C. Order a biomarker test (24%)
  • A. Switch the biologic (11%)
  • B. Switch the MTX (4%)

Start Date: March 21, 2016 @ 10:05 pm
End Date: No Expiry

An otherwise healthy 70-year-old female with GCA will receive high-dose prednisone (30–60 mg) over the next few months. Would you also start prophylactic antibiotic therapy?

  • No (79%)
  • Yes (21%)

Start Date: February 8, 2016 @ 12:54 pm
End Date: No Expiry

In view of the rising prominence of autoimmunity in the pathogenesis of a variety of non-rheumatologic diseases, should future rheumatologists be trained to co-manage some of these conditions?

  • Yes (83%)
  • No (17%)

Start Date: January 8, 2016 @ 12:02 pm
End Date: No Expiry

Looking back at some of the milestone achievements in rheumatology, which one is the most important?

  • A. Use of TNFi (40%)
  • B. Use of MTX (34%)
  • D. Characterization of immunologic pathways (23%)
  • C. MRI imaging of MSK (3%)

Start Date: December 9, 2015 @ 1:00 pm
End Date: No Expiry

A 40-year-old female patient with polymyositis has shown modest improvement following a four-week course of steroids and escalating doses of IM methotrexate (MTX). Her serum CK has dropped from 6100 I

  • Stay the course—no changes (55%)
  • Add rituximab (17%)
  • Add IVIG (12%)
  • Add MYC and maintain MTX (11%)
  • Start mycophenolate (MYC) and withdraw MTX (5%)

Start Date: November 9, 2015 @ 11:17 am
End Date: No Expiry

 Page 3 of 5  «  1  2  3  4  5  » 
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences